64 results on '"Neeland, Ian J."'
Search Results
2. Association of Hepatic Triglyceride Content With Cardiac Structure and Function Among Community-Dwelling Adults
3. Second-Year Results from CINEMA: A Novel, Patient-Centered, Team-Based Intervention for Patients with Type 2 Diabetes or Prediabetes at High Cardiovascular Risk
4. Effects of an oral biodegradable device used for 12 weeks on weight reduction, cardiovascular risk factors, satiety, snacking, and meal size
5. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study
6. Adipo-cardiology: The next frontier in cardiovascular disease
7. Leisure time versus occupational physical activity for cardiometabolic risk
8. Is Metabolically Healthy Obesity Really Healthy for the Heart?
9. Editorial commentary: Weight loss for cardiovascular disease prevention – is semaglutide the answer?
10. Disparities in Statin Prescription Among Patients with Severe Hypercholesterolemia in an Integrated Healthcare System
11. AN OBSERVATIONAL ANALYSIS OF 7,000 PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA: IDENTIFYING AN AGE-TREATMENT GAP IN CARDIOVASCULAR RISK REDUCTION
12. Food insecurity and atherosclerotic cardiovascular disease risk in adults with diabetes
13. Impact of low/no-charge coronary artery calcium scoring on statin eligibility and outcomes in women: The CLARIFY study
14. Relation of coronary calcium scoring with cardiovascular events in patients with diabetes: The CLARIFY Registry
15. Time-Varying Cardiovascular Effects of Finerenone in Diabetic Kidney Disease
16. Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy
17. Contemporary utilization of GLP1 receptor agonists and SGLT2 inhibitors in patients with diagnosed type 2 diabetes and cardiovascular disease in the United States
18. Su1384: ASSOCIATION OF HEPATIC TRIGLYCERIDE CONTENT WITH CARDIAC STRUCTURE AND FUNCTION AMONG COMMUNITY-DWELLING ADULTS: FINDINGS FROM THE DALLAS HEART STUDY
19. Taking the Obesity Paradox to New Heights in Cerebral Atherosclerosis
20. A randomized clinical trial evaluating the effect of empagliflozin on triglycerides in obese adults: Role of visceral fat
21. CORONARY ARTERY CALCIUM SCORING FOR RISK ASSESSMENT IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
22. Cardiometabolic Health Outcomes Associated With Discordant Visceral and Liver Fat Phenotypes: Insights From the Dallas Heart Study and UK Biobank
23. Cardiogenic shock temporally associated with COVID-19 vaccination after prior COVID-19 infection: A case report
24. Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial
25. Management of Obesity in Cardiovascular Practice
26. Effects of Empagliflozin Treatment on Cardiac Biomarkers in Adults With Metabolically Healthy Obesity: Results From a Randomized, Placebo-Controlled Clinical Trial
27. Physical Activity, Subclinical Myocardial Injury, and Risk of Heart Failure Subtypes in Black Adults
28. Eliminating Missed Opportunities for Patients with Type 2 Diabetes
29. 21st Century Advances in Multimodality Imaging of Obesity for Care of the Cardiovascular Patient
30. Prevention and Treatment of Heart Failure
31. Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure
32. EMPAGLIFLOZIN REDUCES ENDOGENOUS GLYCEROL-DEPENDENT HEPATIC GLUCONEOGENESIS IN VISCERALLY OBESE ADULTS WITHOUT TYPE 2 DIABETES MELLITUS
33. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
34. Temporal Changes in Body Fat Distribution and Hypertension
35. Multi-compartment mesenchymal tissue segmentation in pelvic MRI examinations of women: Anthropomorphic and clinical correlations
36. Effect of Exercise and Pharmacological Interventions on Visceral Adiposity: A Systematic Review and Meta-analysis of Long-term Randomized Controlled Trials
37. Association between neighborhood-level socioeconomic deprivation and incident hypertension: A longitudinal analysis of data from the Dallas heart study
38. Intensive Blood Pressure Control and Body Size
39. Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis
40. Inflammation and coronary artery calcification in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study
41. The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study
42. Relationship of Cardiorespiratory Fitness and Adiposity With Left Ventricular Strain in Middle-Age Adults (from the Dallas Heart Study)
43. Defining coronary artery calcium concordance and repeatability - Implications for development and change: The Dallas Heart Study
44. Body Mass Index and Cardiorespiratory Fitness in Mid-Life and Risk of Heart Failure Hospitalization in Older Age
45. Do neighborhoods matter differently for movers and non-movers? Analysis of weight gain in the longitudinal dallas heart study
46. Impact of empagliflozin in patients with diabetes and heart failure
47. Effects of visceral adiposity on glycerol pathways in gluconeogenesis
48. Time to Retire the BMI?
49. Adiponectin predicts incident hypertension independent of body fat accumulation; observations from the dallas heart study
50. Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.